So I read how you rep's do your job to sell the product, let me post from the other side of the fence, from the clinical side.
So around 100,000 a year are fitted and there is a 1% save rate. Of those 100,000 patients fitted, how many patients had arrhythmias that were treated, and how many of those treated arrhythmias were successful?
I don't see any of you answering the above question...
Ive worked in clinical EP cardiology for 7 years now, have had plenty of patients fitted with LifeVest and thankfully none of them have had to be defib'd. But you know what, the patients were happy to have at least a chance at being saved if they did have a life threatening arrhythmia.
There is always a chance that any device will fail, even the implantable PM/ICD/CRT-D have issues, rare, but they do. I've actually seen more patients for inappropriate implanted device therapy and never seen an inappropriate LifeVest therapies in my area.
Yes, its a niche product, yes the corporate structure is performance based. But you know what, technology isn't free, physicians and clinicians forget about products, and goals are often missed as we cannot predict how many patients are going to need devices like this. As preventative medicine improves, I see less people being fitted for LifeVest. But does that mean we slam the product and shelf it? Absolutely not. What we need are committed rep's who know their product, know cardiology and know that nothing is absolute, numbers change and you don't always win.